According to Straits Research, the global nuclear imaging equipment market size was valued at $7.21 billion in 2025 and is projected to reach $9.52 billion by 2034, registering a CAGR of 3.18% during the forecast period 2026–2034. Market Dynamics The nuclear imaging equipment market is driven by growing adoption of molecular imaging for early disease characterization, as clinicians increasingly rely on PET and SPECT systems to visualize metabolic shifts that are undetectable on anatomical imaging alone. However, market expansion is restrained by the limited availability of radiotracer production infrastructure in regions without dedicated radiopharmacy networks, which places operational constraints on facilities seeking to broaden their nuclear imaging services. Despite these challenges, the market presents a strong opportunity through the rapid advancement of targeted radioligand therapies, as clinical trials and treatment programs require high-precision imaging systems for patient selection, treatment planning, and therapeutic monitoring, creating new demand across hospitals and research institutions worldwide. Market Segments By Product (2026-2034) SPECT Imaging Systems Hybrid SPECT Imaging Systems Standalone SPECT Imaging Systems PET Imaging Systems Planar Scintigraphy Imaging Systems By Application (2026-2034) Cardiology Oncology Neurology Others By End Use (2026-2034) Hospitals Imaging Centers R&D Institute Others